Literature DB >> 19917672

Pleiotrophin (PTN) is expressed in vascularized human atherosclerotic plaques: IFN-{gamma}/JAK/STAT1 signaling is critical for the expression of PTN in macrophages.

Fuqiang Li1, Fang Tian, Lai Wang, Ian K Williamson, Behrooz G Sharifi, Prediman K Shah.   

Abstract

Neovascularization is critical to destabilization of atheroma. We previously reported that the angiogenic growth factor pleiotrophin (PTN) coaxes monocytes to assume the phenotype of functional endothelial cells in vitro and in vivo. In this study we show that PTN expression is colocalized with capillaries of human atherosclerotic plaques. Among the various reagents that are critical to the pathogenesis of atherosclerosis, interferon (IFN)-gamma was found to markedly induce PTN mRNA expression in a dose-dependent manner in macrophages. Mechanistic studies revealed that the Janus kinase inhibitors, WHI-P154 and ATA, efficiently blocked STAT1 phosphorylation in a concentration- and time-dependent manner. Notably, the level of phosphorylated STAT1 was found to correlate directly with the PTN mRNA levels. In addition, STAT1/STAT3/p44/42 signaling molecules were found to be phosphorylated by IFN-gamma in macrophages, and they were translocated into the nucleus. Further, PTN promoter analysis showed that a gamma-activated sequence (GAS) located at -2086 to -2078 bp is essential for IFN-gamma-regulated promoter activity. Moreover, electrophoretic mobility shift, supershift, and chromatin immunoprecipitation analyses revealed that both STAT1 and STAT3 bind to the GAS at the chromatin level in the IFN-gamma stimulated cells. Finally, to test whether the combined effect of STAT1/STAT3/p44/42 signaling is required for the expression of PTN in macrophages, gene knockdowns of these transcription factors were performed using siRNA. Cells lacking STAT1, but not STAT3 or p42, have markedly reduced PTN mRNA levels. These data suggest that PTN expression in the human plaques may be in part regulated by IFN-gamma and that PTN is involved in the adaptive immunity.-Li, F., Tian, F., Wang, L., Williamson, I. K., Sharifi, B. G., Shah, P. K. Pleiotrophin (PTN) is expressed in vascularized human atherosclerotic plaques: IFN-gamma/JAK/STAT1 signaling is critical for the expression of PTN in macrophages.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19917672      PMCID: PMC2830133          DOI: 10.1096/fj.09-140780

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  50 in total

1.  Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb.

Authors:  M Arras; W D Ito; D Scholz; B Winkler; J Schaper; W Schaper
Journal:  J Clin Invest       Date:  1998-01-01       Impact factor: 14.808

Review 2.  STATs and gene regulation.

Authors:  J E Darnell
Journal:  Science       Date:  1997-09-12       Impact factor: 47.728

3.  Upregulation of pleiotrophin gene expression in developing microvasculature, macrophages, and astrocytes after acute ischemic brain injury.

Authors:  H J Yeh; Y Y He; J Xu; C Y Hsu; T F Deuel
Journal:  J Neurosci       Date:  1998-05-15       Impact factor: 6.167

4.  Melanoma angiogenesis and metastasis modulated by ribozyme targeting of the secreted growth factor pleiotrophin.

Authors:  F Czubayko; A M Schulte; G J Berchem; A Wellstein
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

5.  Leucocyte recruitment in rupture prone regions of lipid-rich plaques: a prominent role for neovascularization?

Authors:  O J de Boer; A C van der Wal; P Teeling; A E Becker
Journal:  Cardiovasc Res       Date:  1999-02       Impact factor: 10.787

6.  Tenascin-C is expressed in macrophage-rich human coronary atherosclerotic plaque.

Authors:  K Wallner; C Li; P K Shah; M C Fishbein; J S Forrester; S Kaul; B G Sharifi
Journal:  Circulation       Date:  1999-03-16       Impact factor: 29.690

7.  Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils.

Authors:  K Takeda; B E Clausen; T Kaisho; T Tsujimura; N Terada; I Förster; S Akira
Journal:  Immunity       Date:  1999-01       Impact factor: 31.745

8.  Induction of heparin-binding growth-associated molecule expression in reactive astrocytes following hippocampal neuronal injury.

Authors:  A Takeda; H Onodera; A Sugimoto; Y Itoyama; K Kogure; H Rauvala; S Shibahara
Journal:  Neuroscience       Date:  1995-09       Impact factor: 3.590

9.  Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: generation and characterization of T cell-specific Stat3-deficient mice.

Authors:  K Takeda; T Kaisho; N Yoshida; J Takeda; T Kishimoto; S Akira
Journal:  J Immunol       Date:  1998-11-01       Impact factor: 5.422

10.  Involvement of heparin affin regulatory peptide in human prostate cancer.

Authors:  F Vacherot; D Caruelle; D Chopin; S Gil-Diez; D Barritault; J P Caruelle; J Courty
Journal:  Prostate       Date:  1999-02-01       Impact factor: 4.104

View more
  9 in total

1.  Tenascin-C deficiency in apo E-/- mouse increases eotaxin levels: implications for atherosclerosis.

Authors:  Lai Wang; Prediman K Shah; Wei Wang; Lei Song; Mingjie Yang; Behrooz G Sharifi
Journal:  Atherosclerosis       Date:  2013-02-11       Impact factor: 5.162

2.  Elevated expression of pleiotrophin in human hypertrophic scars.

Authors:  Qian Zhang; Kai Tao; Wei Huang; Yaguang Tian; Xiaoyan Liu
Journal:  J Mol Histol       Date:  2012-09-28       Impact factor: 2.611

Review 3.  From top to bottom: midkine and pleiotrophin as emerging players in immune regulation.

Authors:  Noah Sorrelle; Adrian T A Dominguez; Rolf A Brekken
Journal:  J Leukoc Biol       Date:  2017-03-29       Impact factor: 4.962

4.  Gene expression suggests spontaneously hypertensive rats may have altered metabolism and reduced hypoxic tolerance.

Authors:  Marie-Françoise Ritz; Caspar Grond-Ginsbach; Stefan Engelter; Philippe Lyrer
Journal:  Curr Neurovasc Res       Date:  2012-02       Impact factor: 1.990

5.  Genes involved in systemic and arterial bed dependent atherosclerosis--Tampere Vascular study.

Authors:  Mari Levula; Niku Oksala; Nina Airla; Rainer Zeitlin; Juha-Pekka Salenius; Otso Järvinen; Maarit Venermo; Teemu Partio; Jukka Saarinen; Taija Somppi; VeliPekka Suominen; Jyrki Virkkunen; Juha Hautalahti; Reijo Laaksonen; Mika Kähönen; Ari Mennander; Leena Kytömäki; Juhani T Soini; Jyrki Parkkinen; Markku Pelto-Huikko; Terho Lehtimäki
Journal:  PLoS One       Date:  2012-04-11       Impact factor: 3.240

6.  A meta-analysis on the role of pleiotrophin (PTN) as a prognostic factor in cancer.

Authors:  Jiupeng Zhou; Yuanli Yang; Yongfeng Zhang; Heng Liu; Quanli Dou
Journal:  PLoS One       Date:  2018-11-14       Impact factor: 3.240

7.  Pleiotrophin Expression and Actions in Pancreatic β-Cells.

Authors:  Julio Sevillano; Aileen Liang; Brenda Strutt; Thomas G Hill; Sandra Szlapinski; Maria Pilar Ramos-Álvarez; David J Hill
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-18       Impact factor: 5.555

8.  Circulating Proteomic Signatures of Chronological Age.

Authors:  Cristina Menni; Steven J Kiddle; Massimo Mangino; Ana Viñuela; Maria Psatha; Claire Steves; Martina Sattlecker; Alfonso Buil; Stephen Newhouse; Sally Nelson; Stephen Williams; Nicola Voyle; Hilkka Soininen; Iwona Kloszewska; Patrizia Mecocci; Magda Tsolaki; Bruno Vellas; Simon Lovestone; Tim D Spector; Richard Dobson; Ana M Valdes
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-08-14       Impact factor: 6.053

9.  Association of Midkine and Pleiotrophin Gene Polymorphisms With Systemic Lupus Erythematosus Susceptibility in Chinese Han Population.

Authors:  Peng Wang; Yan-Mei Mao; Chan-Na Zhao; Jie-Bing Wang; Xiao-Mei Li; Dong-Qing Ye; Hai-Feng Pan
Journal:  Front Immunol       Date:  2020-02-21       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.